Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.

about

IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis

P2860

Q58699771-1D69780D-CE1F-4704-96FD-93FAD0E0D800

P2860

Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.

Item

http://www.wikidata.org/entity/Q48636743

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Erlotinib attenuates the progr ...... e in rats with remnant kidney.

@en

Erlotinib attenuates the progr ...... e in rats with remnant kidney.

@nl

type

Item

label

Erlotinib attenuates the progr ...... e in rats with remnant kidney.

@en

Erlotinib attenuates the progr ...... e in rats with remnant kidney.

@nl

prefLabel

Erlotinib attenuates the progr ...... e in rats with remnant kidney.

@en

Erlotinib attenuates the progr ...... e in rats with remnant kidney.

@nl

P1476

Erlotinib attenuates the progr ...... se in rats with remnant kidney

@en

P2093

Kei Fukuda-Hihara

http://www.w3.org/2001/XMLSchema#string

Kei Matsumoto

http://www.w3.org/2001/XMLSchema#string

Masayuki Iyoda

http://www.w3.org/2001/XMLSchema#string

Shohei Tachibana

http://www.w3.org/2001/XMLSchema#string

Taihei Suzuki

http://www.w3.org/2001/XMLSchema#string

Takanori Shibata

http://www.w3.org/2001/XMLSchema#string

Tomohiro Saito

http://www.w3.org/2001/XMLSchema#string

Yasutaka Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yukihiro Wada

http://www.w3.org/2001/XMLSchema#string

P2860

GLIPR-2 overexpression in HK-2 cells promotes cell EMT and migration through ERK1/2 activation

Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney

Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure

Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model

TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats

EGFR signaling promotes TGFβ-dependent renal fibrosis

Nitric oxide modulates vascular disease in the remnant kidney model.

Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway.

P304

598-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFX264

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

K Iseri

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28992288

http://www.w3.org/2001/XMLSchema#string

Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.

about

P2860

P2860

Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698